Clinical Trial Update: Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates anti-VEGF intravitreous injections for diabetic macular edema in patients undergoing cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Diabetic Macular Edema

Snippet

Sponsor: Second Military Medical University | Conditions: Diabetic Macular Edema, Cataract | Phase 3 | Status: UNKNOWN